Uncategorized

Merck Beat Quarterly Forecasts. So Why Did It Plummet 10%? – Investor’s Business Daily

Posted on Author Tim Hodges Comments Off on Merck Beat Quarterly Forecasts. So Why Did It Plummet 10%? – Investor’s Business Daily
  1. Merck Beat Quarterly Forecasts. So Why Did It Plummet 10%?  Investor’s Business Daily
  2. Merck & Co. (MRK) Halts Gardasil Sales in China, Dragging on 2025 Outlook  Bloomberg
  3. Merck’s earnings miss focused attention on Gardasil. The real issue is Keytruda  STAT
  4. Merck shares plunge as company pauses Gardasil vaccine shipments in China, hurting 2025 outlook  CNBC
  5. Our Q4 and full-year 2024 financial results  Merck